Mary DiGiorgi, PhD, MPH

Senior Vice President of Clinical Development and Medical Strategy
Pacira BioSciences, Inc

Poster(s):

• (1) Intraoperative liposomal bupivacaine is associated with improved pain, opioid use, functional, and length of stay outcomes after total knee arthroplasty: real-world evidence
  Wednesday, October 29, 2025

• (4) Impact of liposomal bupivacaine on healthcare resource utilization and costs in patients undergoing total knee arthroplasty in real-world ambulatory surgical centers
  Wednesday, October 29, 2025